Bionano Genomics Inc (BNGO)
1.135
+0.02
(+2.25%)
USD |
NASDAQ |
May 17, 16:00
1.135
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Revenue (Annual): 36.12M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.12M |
| December 31, 2022 | 27.80M |
| December 31, 2021 | 17.98M |
| December 31, 2020 | 8.503M |
| Date | Value |
|---|---|
| December 31, 2019 | 10.13M |
| December 31, 2018 | 12.00M |
| December 31, 2017 | 9.505M |
| December 31, 2016 | 6.793M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
8.503M
Minimum
2020
36.12M
Maximum
2023
20.11M
Average
17.98M
Median
2021
Revenue (Annual) Benchmarks
| Azenta Inc | 665.07M |
| Harvard Bioscience Inc | 112.25M |
| Standard BioTools Inc | 106.34M |
| Akoya Biosciences Inc | 96.63M |
| Singular Genomics Systems Inc | 2.911M |